Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98183623 | 9818362 | 3 | F | 2011 | 20160919 | 20140115 | 20160922 | PER | US-PFIZER INC-2014006728 | PFIZER | 43.00 | YR | F | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98183623 | 9818362 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 300 MG, 4X/DAY | Y | 20235 | 300 | MG | QID | ||||||
| 98183623 | 9818362 | 2 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | UNK | U | 19999 | ||||||||||
| 98183623 | 9818362 | 3 | SS | IRON | IRON | 1 | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98183623 | 9818362 | Drug hypersensitivity | |
| 98183623 | 9818362 | Hallucination | |
| 98183623 | 9818362 | Panic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98183623 | 9818362 | 1 | 2011 | 2011 | 0 |